Showing results (1681-1690 of 25,161) with videos related to
Sort By:
Pageof 2,517
Oncotarget|October 28, 2015
Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcomaJu-Fang Liu, Ya-Ting Tsao, Chun-Han HouOncotarget|October 28, 2015
CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysisLi Yiming, Guo Yunshan, Ma Bo, et al.Oncotarget|October 28, 2015
Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanomaDavid S Hong, Razelle Kurzrock, Gerald S Falchook, et al.Oncotarget|October 30, 2015
Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinomaArvydas Laurinavicius, Andrew R Green, Aida Laurinaviciene, et al.Oncotarget|October 30, 2015
MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3Yue Teng, Yan Zhang, Kai Qu, et al.Oncotarget|October 31, 2015
Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signalsChangYi Lin, WanYing Lin, Shuyuan Yeh, et al.Oncotarget|October 31, 2015
A combination of tyrosine kinase inhibitors, crizotinib and dasatinib for the treatment of glioblastoma multiformeHayley Nehoff, Neha N Parayath, Melanie J McConnell, et al.Oncotarget|October 31, 2015
Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathwaysNicola Bortel, Sorin Armeanu-Ebinger, Evi Schmid, et al.Oncotarget|October 31, 2015
BRCA1/2 mutations perturb telomere biology: characterization of structural and functional abnormalities in vitro and in vivoOrit Uziel, Rinat Yerushalmi, Lital Zuriano, et al.Oncotarget|October 31, 2015
In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancerToshiyuki Hirano, Hiroyuki Yasuda, Tetsuo Tani, et al.Pageof 2,517